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BRIEF COMMUNICATION
Multiple lentigines (ML)/LEOPARD syndrome
(LS; MIM#151100), described for the first time 
by Gorlin et al in 1969,1 is a rare disorder that is
transmitted as an autosomal-dominant trait. The
acronym LEOPARD was named to recall the syn-
drome: L, lentigines; E, electrocardiographic con-
duction abnormalities; O, ocular hypertelorism;
P, pulmonary stenosis; A, abnormalities of geni-
talia; R, retardation of growth; and D, deafness
(sensorineural). Voron et al2 proposed diagnostic
criteria for LS. According to these criteria, more
than 100 cases have been described.2–5
Since 2002, a missense mutation in the PTPN11
gene has been found in LS.6,7 According to one
large study, about 90% of LS cases harbor PTPN11
gene mutations.4,5 Here, we report the clinical
presentation and mutation analysis of four
Taiwanese children with LS.
Patients and Methods
Patients
Four patients were diagnosed with LS at dermatol-
ogy and/or genetic counseling clinics at National
Cheng Kung University Hospital, Tainan, Taiwan.
For diagnosis of LS, the presence of lentigines
was required, in combination with at least one 
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Background/Purpose: LEOPARD syndrome (LS) is a rare, autosomal dominant disorder. The typical clinical
presentation includes multiple lentigines and cardiac defects. Mutation analysis of the PTPN11 gene is
feasible. We report four cases of LS, which were confirmed by molecular genetic study.
Methods: The clinical features and mutations of the four patients were summarized.
Results: The diagnosis of all four patients was made when lentigines appeared during childhood. Three
cases had hypertrophic cardiomyopathy. No electrocardiographic conduction abnormality was noted in any
of the cases. Three patients had hypertelorism and three had short stature. Two patients, identical twins,
presented with the atypical phenotype of tongue protrusion and hepatosplenomegaly at birth. Twin B had
mild mental retardation. Case 4 had moderate hearing impairment. Point mutation of the PTPN11 gene
was found in all patients.
Conclusion: LS has typical skin manifestations. All patients should undergo a comprehensive examination,
especially echocardiography and electrocardiography. The diagnosis can be confirmed by genetic study. 
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of the cardinal features outlined by Voron et al.2
Clinical evaluation included family history, 
complete physical examination, hearing test, elec-
trocardiography (ECG) and echocardiography.
Peripheral blood samples were collected from
the four patients. If their parents had the LS phe-
notype, samples were also collected for mutation
analysis.
Screening of PTPN11
Point mutations were identified by sequence
analysis of amplified DNA that contained the
PTPN11 gene.
Results
Clinical presentation
There were one female and three male patients.
All cases were identified initially by ML. Other
clinical presentations are summarized in the Table.
Cases 1 and 2 were premature identical twins. At
the neonatal stage, the initial clinical presentation
included protruding tongue, hepatosplenomegaly
and hypertrophic cardiomyopathy. In both twins,
the severity of tongue protrusion subsided with
time. Around 8 years of age, typical lentigines ap-
peared and LS was diagnosed. The skin lesion ap-
peared in case 3 at the age of 7 years (Figure) and
6 years in case 4. The mother of case 3 also had ML.
Ocular hypertelorism was noted in three
cases. Hypertrophic cardiomyopathy (HCM), the
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Figure. On examination, typical lentigines were evident
over the face.
Table. Pooled clinical data for four cases
Case 1 (Twin A) Case 2 (Twin B) Case 3 Case 4
Age at diagnosis 8 yr 8 yr 7 yr 6 yr
Sex Male Male Female Male
Lentigines + + + +
ECG conduction abnormalities – – – –
Ocular hypertelorism + + + –
Heart defect HCM HCM Pulmonary stenosis Left ventricular
status post balloon chamber 
valvuloplasty hypertrophy
Short stature + + 10th centile +
(body height < 3rd centile)
Mental retardation – Mild – –
Deafness Normal Normal Normal Bilateral moderate 
hearing impairment
Other abnormalities Tongue protrusion, Tongue protrusion, 
hepatosplenomegaly hepatosplenomegaly
PTPN11 mutation
Patient Exon 12 (T468M), Exon 12 (T468M), Exon 12 (T468M), Exon 12 (G464A), 
C1403T C1403T C1403T G1391C
ECG = electrocardiography; HCM = hypertrophic cardiomyopathy.
most common heart defect in LS, was noted in
three cases. Pulmonary stenosis (PS) was noted
in case 3. None of the patients had any conduc-
tion abnormality revealed by ECG. Development
and growth were the two major issues for patients
with LS. Three patients had short stature (height
below the 3rd centile). Twin B had mild mental
retardation. Case 4 suffered from moderate hear-
ing impairment.
Mutation analysis
The point mutation T468M that changes amino
acid 468 from threonine to methionine was
identified in the twins, case 3 and her mother. In 
case 4, another point mutation, G464A, changed
amino acid 464 from glycine to alanine.
Discussion
Lentigines
The phenotype of ML is the most distinct feature
of LS. A French multicenter study pooled 30
cases, among which 28 had lentiginosis.4 Sarkozy
et al reported 30 cases and ML were also present
in most cases (86%).5 The lesions presented as
flat, black–brown macules all over the body, but
mostly on the face, neck and upper part of the
trunk. They develop classically during childhood,
increasing in number and darkening in color
with age.8 In the twins presented here, their skin
lesion did not appear at birth. The diagnosis was
not made until the age of 8 years when lentigines
appeared. In the literature review, the mean age
at report was also around infancy and during
childhood.4,5
Electrocardiographic conduction and 
cardiac structural abnormalities
Electrocardiographic conduction abnormalities
and PS were the two major criteria proposed by
Gorlin et al.3 HCM was more common than PS.
Sarkozy et al5 reported 30 cases in which there
were two cases with arrhythmia, three with PS,
and 14 with HCM. Other cardiac abnormalities,
including aortic stenosis,4 atrioventricular canal
defect, mitral valve anomalies,5 and cardiac myx-
oma9 have been reported.
Cardiac structural and conduction abnormal-
ities are the major determinants of mortality and
morbidity in LS. Sudden cardiac death has previ-
ously been reported in patients with LS.10,11 The
two previously reported patients both had HCM
and conduction abnormalities.
Three of our four cases had HCM. Case 3 had
severe valvular PS. Conduction abnormalities in
LS have been reported to occur gradually and pro-
gressively.9 Fortunately, no conduction abnormal-
ity was noted during the regular follow-up of our
cases.
Ocular hypertelorism
Reviewing the literature, the clinical presentation
of hypertelorism is quite common, and this sign
was also noted in three of our patients.
Genital abnormalities
Genital abnormalities include hypospadias and
cryptorchidism.12 In 1984, Colomb and Morel13
reviewed 38 cases and found that 29% had ab-
normal genitalia (males). No genital abnormality
was noted in our cases.
Deafness (sensorineural)
Sensorineural hearing loss has been documented
in about 25% of patients with LS.2,12 Hearing
impairment can be detected early in the neonatal
stage by auditory brainstem response audiometry
(ABR). Our twins were diagnosed with hearing
impairment at birth by ABR. During follow-up,
both of their hearing was normal, as confirmed by
pure-tone testing. Case 4 had bilateral moderate
hearing impairment (right ear: 102 db; left ear:
87 db), and is wearing a hearing aid at present.
Growth and mental retardation
Colomb and Morel reported that 42% of LS had
short stature.12,13 In our patients, three had short
stature (height below the 3rd centile). The height
of case 4 was around the 10th centile.
Colomb and Morel reported mental retarda-
tion in 35% of cases.12,13 Sarkozy et al reviewed
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30 cases and eight had mental retardation.5 In
our cases, according to the Wechsler Primary and
Preschool Scale of Intelligence-Revised (WPPSI-R),
only twin B had mental retardation during 
follow-up.
Other clinical manifestations
The presence of tongue protrusion and hepato-
splenomegaly in our twins has not been mentioned
previously. The etiology of hepatosplenomegaly
was investigated. No evidence of congenital in-
fection was found. Liver biopsy showed no evi-
dence of glycogen storage or other hepatic disease.
The tongue protrusion subsided gradually with
age. However, the hepatosplenomegaly persisted
during follow-up.
Mutations in PTPN11 gene
The PTPN11 gene encodes the protein tyrosine
phosphatase SHP-2, which contains two Src ho-
mology 2 (SH2) domains. SHP-2 is a critical com-
ponent of signal transduction for several growth
factor-, hormone-, and cytokine-signaling path-
ways that control developmental processes and
hematopoiesis, as well as energy balance and
metabolism.14 With the crucial role of SHP-2 in
development, germline mutations in PTPN11 have
been identified in cases of LS, Noonan syndrome
and hematologic malignancies, including juve-
nile myelomonocytic leukemia, myelodysplastic
syndromes, acute myeloid leukemia,15 and acute
lymphoblastic leukemia.14
In 2002, two teams first reported that patients
with LS also had mutations in PTPN11.6,7 The
mutations account for up to 90% of cases.4,14
Among all mutations, T468M and Y279C account
for the majority of cases. No specific genotype–
phenotype correlation has been found. Further
study is needed in Asian patients to identify if there
are racial differences in the point mutations.
The point mutations T468M4,6,14 and
G464A5,14 that were found in our cases have been
reported in the literature. The mother of case 3
also had the same mutation as her daughter. In
the other three cases, according to family history,
we believe that the mutations occurred de novo.
Conclusion
As a rare disease, LS can be identified by the typical
feature of ML. For the wide spectrum of the 
syndrome, all patients should receive compre-
hensive examination, including echocardiography
and ECG by cardiologists. A hearing test is also
warranted. For the high prevalence of short stature
and mental retardation, all patients need close
follow-up by pediatricians and might require early
intervention. At present, molecular analysis en-
ables us to confirm the diagnosis and make 
genetic counseling and prenatal diagnosis more
accurate.
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